The development of new drugs and biological medicines draws on the talent, passion and experience of a wide range of professionals. The goal of The Medicine Maker is to integrate all aspects of the process, from the registration of an Investigational New Drug (IND) or Biologics License Application (BLA) through to the market launch of new therapies, and beyond.
The Medicine Maker combines topical news coverage with practical, pragmatic articles that are meaningful to the daily working life of experts in the clinical, regulatory, development and manufacturing fields. Feature articles tell the stories behind the biggest concepts, issues and advances in the field, and departments will cover topics in business, policy to advice and career development.
The Medicine Maker launched in September 2014, and is available in a multitude of formats; contemporarily designed print magazine, interactive app in Apple’s App Store (iPad and iPhone), and a responsive-design website serving the full range of digital solutions life science marketers have come to expect. We also engage with our audience via Facebook, Google+, Twitter and LinkedIn. Source